Funds / Mutual Funds / Scheme 135810
Tata India Pharma & Healthcare Fund
Direct Plan · Growth Option · Tata Mutual Fund · scheme code 135810 · ISIN INF277K019A3
- Scheme code
- 135810
- Latest NAV
- ₹39.6834
- NAV date
- 23 Sep 2026
- Fund house
- Tata Mutual Fund
Reading this dossier
Data, not advice. These pages show NAV history, category and computed returns as published by AMFI, so funds can be compared side by side. StockProof does not rank funds, does not score them, and does not recommend buying, selling or holding any of them. Past NAV movement is not an indication of future returns.
Fund names here are CURRENT names, not the name the fund had on the date shown. AMFI retroactively restates historical scheme names to whatever the fund is called today: its own April 2006 file lists schemes under "Nippon India Mutual Fund", a fund house that did not exist until 2019 (it was Reliance). Measured on 2026-08-29, all 1,947 scheme codes present in both AMFI's 2018 and 2026 files showed zero name changes — not because renames are rare in the Indian fund industry, but because the history is rewritten. StockProof stores and shows only the current name and does not attempt to reconstruct point-in-time names, because AMFI publishes nothing that would make that possible. The NAV figures themselves are as published for each date and are not restated.
Long-window returns are measured only over funds that still exist. Of the 1,790 scheme codes AMFI priced in April 2006, only 568 (31%) were still being priced in 2026. Funds that closed or merged are not in a long-period comparison, so any group of surviving funds looks better than the choice an investor actually faced at the time.
Benchmark, benchmark return and AUM figures on this page are AMFI's own published disclosure — the same SEBI-mandated benchmark every fund must declare and report against, sourced from AMFI's Fund Performance data. StockProof does not compute the benchmark return itself: it shows the number AMFI and the fund house publish, exactly as published. StockProof does not rank funds or benchmarks by this figure, and this is not a recommendation to buy, sell or hold anything.
This section is matched to the scheme above by FUND NAME, not by scheme code or ISIN — AMFI's benchmark-disclosure API carries neither, unlike its NAV files. Measured 2026-08-29 across the whole universe, this name match succeeds for about 86% of funds; most misses are small spelling or punctuation drift between AMFI's own two systems, not a wrong match — a fund with no match here simply shows no data rather than another fund's. One disclosed row also covers BOTH the Regular and Direct plan of a fund together, because that is the granularity AMFI itself publishes at — one level coarser than the per-plan scheme codes StockProof otherwise tracks.
Scheme
| Latest NAV | ₹39.6834 |
|---|---|
| NAV date | 23 Sep 2026 |
| Category | Equity · Sectoral / Thematic |
| Structure | Open Ended |
| Status | Open — priced in AMFI's latest file |
| As published by AMFI | Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)
StockProof normalizes AMFI's 104 category spellings onto 56 categories; this is the raw string behind the one shown above. |
| Stored NAV history | 750 points, 01 Sep 2023 → 23 Sep 2026 |
Benchmark & AUM
No AMFI benchmark/AUM disclosure has been matched to this scheme yet — either it has not been fetched (run python manage.py refresh_fund_benchmarks), or its name did not match AMFI's fund-performance data on the last run.
Returns (CAGR)
Compound annual growth of NAV over each trailing window, computed from stored history with the same function the company pages use. A window is only shown as a number when the stored history genuinely reaches back that far — it is never computed over a shorter span and labelled as the longer one.
| Window | CAGR | Basis |
|---|---|---|
| 1-year | 10.29% | NAV 35.9827 on 23 Sep 2025 to 39.6834 on 23 Sep 2026 (1-year, AMFI) |
| 3-year | 20.98% | NAV 22.3971 on 22 Sep 2023 to 39.6834 on 23 Sep 2026 (3-year, AMFI) |
| 5-year | N/A | Stored NAV history starts 01 Sep 2023, which does not reach back a full 5 years from 23 Sep 2026. |
| 10-year | N/A | Stored NAV history starts 01 Sep 2023, which does not reach back a full 10 years from 23 Sep 2026. |
| Since stored history begins | 20.68% | NAV 22.3220 on 01 Sep 2023 to 39.6834 on 23 Sep 2026 (3.1 years stored, AMFI) |
"Since stored history begins" is deliberately not called "since inception" — AMFI publishes no NAV before 1 April 2006, so for an older fund its true inception NAV is not in any public AMFI feed.
Holdings X-ray
These holdings are the fund house's own SEBI-mandated monthly portfolio disclosure, read from the file the AMC publishes and shown as published. StockProof does not estimate, model or infer a single holding. The portfolio is a SNAPSHOT on the date shown — usually a month-end — and a fund can and does trade in between, so what it holds today is not necessarily what is listed here. Nothing on this page ranks funds, scores them, or recommends buying, selling or holding anything.
StockProof can only link a holding to a company page if that company is in the Nifty 500 universe it tracks. Everything the fund disclosed is listed here either way — holdings outside that universe are shown with their real names and weights and counted explicitly as "outside tracked universe", never dropped. Two coverage figures are given because they can differ enormously and either one alone is misleading: the share of holding LINES that link, and the share of disclosed WEIGHT that links. Parag Parikh Flexi Cap Fund is the standing example — under half its lines link, but around three-quarters of its weight does, because its unlinked positions are a handful of very large US holdings.
Coverage varies enormously by fund type and low coverage is a fact about the universe boundary, not a defect. Large-cap, flexi-cap and index funds typically X-ray at over 90% of disclosed weight; small-cap funds fall to roughly 44–75%, because much of what they own sits below the Nifty 500; and a pure debt fund links at zero, because bonds are not companies in StockProof's universe at all. Read the coverage figure before reading the holdings: at 45% coverage the listed companies are a minority of the fund.
The disclosed holdings usually do not add to 100% of the fund. The remainder is cash, TREPS, repo and derivative margin, which the AMC reports without a security line. Weights here are the AMC's own "% to NAV" figures, so they are shares of the WHOLE fund and can be added up directly — but the total falling short of 100% is normal and is shown rather than scaled away.
Holdings are matched to companies by ISIN — the security's own permanent identifier, never by name — so a matched company is the security the fund disclosed and not a guess. The FUND itself is matched to this page by NAME, which is weaker: measured 2026-08-30 across 625 portfolios, that name match succeeds for about 91% of funds, because the AMC's file carries no AMFI scheme code. A fund with no match simply shows no holdings section rather than another fund's. One disclosed portfolio also covers every plan and option of a fund at once, since that is the granularity the fund house publishes at.
How much of this fund StockProof can show
| Of the weight the fund disclosed, tracked | 74.4% | 74.1% of NAV, out of the 99.5% the fund disclosed in security lines |
|---|---|---|
| Of the holding lines disclosed, tracked | 68.3% | 28 of 41 positions. This can differ sharply from the weight figure above — a few very large untracked holdings move one and not the other. |
| Outside StockProof's tracked universe | 13 | 25.4% of NAV — listed in full below with real names and weights, never dropped |
| Not in any security line | 0.5% | cash, TREPS, repo and derivative margin, which the fund house reports without a security line |
Portfolio as disclosed by TATA INDIA PHARMA & HEALTHCARE FUND on 31 Aug 2026, read from the fund house's own published file (sheet TIPHF). The unit check passed: 99.49% of NAV over 41 lines is consistent with 'percent'.
| Holding | Industry / rating | % of NAV | Tracked |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD INE044A01036 | Pharmaceuticals & Biotechnology | 8.43% | on StockProof |
| HEALTHCARE GLOBAL ENTERPRISES LTD INE075I01017 | Healthcare Services | 6.30% | outside tracked universe |
| DIVI LABORATORIES LTD INE361B01024 | Pharmaceuticals & Biotechnology | 5.65% | on StockProof |
| ABBOTT INDIA LTD INE358A01014 | Pharmaceuticals & Biotechnology | 5.44% | outside tracked universe |
| RAINBOW CHILDRENS MEDICARE LTD INE961O01016 | Healthcare Services | 4.47% | on StockProof |
| APOLLO HOSPITALS ENTERPRISE LTD INE437A01024 | Healthcare Services | 4.32% | on StockProof |
| CIPLA LTD INE059A01026 | Pharmaceuticals & Biotechnology | 4.27% | on StockProof |
| DR REDDYS LABORATORIES LTD INE089A01031 | Pharmaceuticals & Biotechnology | 4.21% | on StockProof |
| MAX HEALTHCARE INSTITUTE LTD INE027H01010 | Healthcare Services | 3.80% | on StockProof |
| FORTIS HEALTHCARE LTD INE061F01013 | Healthcare Services | 3.30% | on StockProof |
| LUPIN LTD INE326A01037 | Pharmaceuticals & Biotechnology | 3.26% | on StockProof |
| SYNGENE INTERNATIONAL LTD INE398R01022 | Healthcare Services | 3.02% | on StockProof |
| BAYER CROPSCIENCE LTD INE462A01022 | Fertilizers & Agrochemicals | 3.01% | outside tracked universe |
| PFIZER LTD INE182A01018 | Pharmaceuticals & Biotechnology | 2.92% | on StockProof |
| MANKIND PHARMA LTD INE634S01028 | Pharmaceuticals & Biotechnology | 2.91% | on StockProof |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD INE159A01016 | Pharmaceuticals & Biotechnology | 2.72% | on StockProof |
| PROCTER & GAMBLE HEALTH LTD INE199A01012 | Pharmaceuticals & Biotechnology | 2.51% | outside tracked universe |
| SAI LIFE SCIENCES LTD INE570L01029 | Pharmaceuticals & Biotechnology | 2.41% | on StockProof |
| ALKEM LABORATORIES LTD INE540L01014 | Pharmaceuticals & Biotechnology | 2.35% | on StockProof |
| ANTHEM BIOSCIENCES LTD INE0CZ201020 | Pharmaceuticals & Biotechnology | 2.14% | on StockProof |
| FDC LTD INE258B01022 | Pharmaceuticals & Biotechnology | 2.10% | outside tracked universe |
| GLOBAL HEALTH LTD INE474Q01031 | Healthcare Services | 1.68% | on StockProof |
| DR. LAL PATH LABS LTD INE600L01024 | Healthcare Services | 1.66% | on StockProof |
| ASTER DM QUALITY CARE LTD INE914M01019 | Healthcare Services | 1.59% | on StockProof |
| SUMITOMO CHEMICAL INDIA LTD INE258G01013 | Fertilizers & Agrochemicals | 1.59% | on StockProof |
| AJANTA PHARMA LTD INE031B01049 | Pharmaceuticals & Biotechnology | 1.57% | on StockProof |
| ACUTAAS CHEMICALS LTD INE00FF01025 | Pharmaceuticals & Biotechnology | 1.48% | on StockProof |
| MANIPAL HEALTH ENTERPRISES LTD INE459N01021 | Healthcare Services | 1.24% | outside tracked universe |
| METROPOLIS HEALTHCARE LTD INE112L01020 | Healthcare Services | 1.11% | outside tracked universe |
| GILLETTE INDIA LTD INE322A01010 | Personal Products | 1.09% | on StockProof |
| BIOCON LTD INE376G01013 | Pharmaceuticals & Biotechnology | 0.99% | on StockProof |
| PI INDUSTRIES LTD INE603J01030 | Fertilizers & Agrochemicals | 0.95% | on StockProof |
| IPCA LABORATORIES LTD INE571A01038 | Pharmaceuticals & Biotechnology | 0.90% | on StockProof |
| MOLBIO DIAGNOSTICS LTD INE869T01028 | Healthcare Services | 0.87% | outside tracked universe |
| DR. AGARWALS HEALTH CARE LTD INE943P01029 | Healthcare Services | 0.71% | outside tracked universe |
| SYMBIOTEC PHARMALAB LTD INE899I01028 | Pharmaceuticals & Biotechnology | 0.64% | outside tracked universe |
| SANOFI CONSUMER HEALTHCARE INDIA LTD INE0UOS01011 | Pharmaceuticals & Biotechnology | 0.52% | outside tracked universe |
| HDFC LIFE INSURANCE CO. LTD INE795G01014 | Insurance | 0.50% | outside tracked universe |
| ZIM LABORATORIES LTD INE518E01015 | Pharmaceuticals & Biotechnology | 0.49% | outside tracked universe |
| JUBILANT PHARMOVA LTD INE700A01033 | Pharmaceuticals & Biotechnology | 0.25% | on StockProof |
| TORRENT PHARMACEUTICALS LTD INE685A01028 | Pharmaceuticals & Biotechnology | 0.12% | on StockProof |
Every line the fund house disclosed is listed above, in the order it weighs. Weights are the fund house's own "% to NAV" figures, normalised to a percentage of the whole fund; they are not rescaled to add to 100%.
Active share & tracking error
Active share (Cremers & Petajisto, 2009) is half the sum of the absolute difference between this fund's disclosed weight and the benchmark proxy's disclosed weight, security by security. Tracking error (Roll, 1992) is the annualized standard deviation of the daily difference between this fund's return and the proxy's, over the days both have a stored NAV. Neither is a rating or a score; both describe how much this fund's actual holdings and returns differ from a portfolio that simply held the benchmark.
StockProof has no official total-return index (TRI) data — the price feed it stores tracks an index's PRICE only, which understates a real TRI benchmark by roughly its dividend yield. Instead, both figures are computed against another fund: an index fund that tracks the same benchmark, whose own NAV already reflects reinvested dividends and whose own disclosed portfolio stands in for the benchmark's constituent weights. Measured directly: two different index funds on the same benchmark differ from each other by only 2–3 basis points a year of tracking error — two orders of magnitude below any actively managed fund's real figure — which is what licenses using one as a stand-in for the true benchmark. This proxy is hand-picked and verified for 24 declared benchmarks; a fund benchmarked to anything else shows no active share or tracking error, not a guessed one.
Not available — no declared benchmark is on file for this fund.